EZH2 and cancer: EZH2 overexpression is closely associated with immune suppression in various cancers, as it can downregulate antigen presentation, induce immune checkpoint molecules, and modulate immune cell function, collectively enabling cancer cells to evade immune surveillance and escape immune-mediated destruction32–34.